. . . . . . . . . . . . "a(SCHEM:Lumiliximab) -| p(HGNC:CD86)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Furthermore, the addition of lumiliximab to cytokine stimulated U937 cells reduced surface expression of CD86 " . . "Selventa" . . . . "2014-07-03T14:30:38.642+02:00"^^ . . .